Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future?
- PMID: 31167883
- DOI: 10.1183/13993003.00583-2019
Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future?
Conflict of interest statement
Conflict of interest: A.L. Theilmann has nothing to disclose. Conflict of interest: M.L. Ormiston has nothing to disclose.
Comment on
-
Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension.Eur Respir J. 2019 Jun 5;53(6):1800965. doi: 10.1183/13993003.00965-2018. Print 2019 Jun. Eur Respir J. 2019. PMID: 31023847
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous